Clinical Trial Update: First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine [Phase 1]

View source ↗

Summary

This document reports the completion of the first adult safety trial (Phase 1) of an intranasal live attenuated Bordetella pertussis vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• Nasal live attenuated Bordetella pertussis vaccine (live attenuated intranasal Bordetella pertussis vaccine)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Pertussis | Phase 1 | Status: COMPLETED